Wei Yang
Impact in
- Pharmaceutical Science top 2%
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- Cancer, Lipids, and Metabolism
Papers in
-
- MicroRNA in disease regulation 8
- Co-authors
- Robert O. WilliamsKeith P. JohnstonRongmin YuLiyan SongNathan P. WiederholdChunyan YanZhang ZhangYu Zhao
- Journals
- Biochemical and Biophysical Research Communications (3 papers)Scientific Reports (2 papers)International Journal of Medical Sciences (2 papers)BMC Veterinary Research (2 papers)European Journal of Pharmacology (2 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Wei Yang
113 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 145
- Pharmaceutical Science 177
- Cancer Research 401
- Developmental Neuroscience 83
- Pharmacology 275
- Molecular Biology 1.1k
Countries citing papers authored by Wei Yang
This map shows the geographic impact of Wei Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Yang more than expected).
Fields of papers citing papers by Wei Yang
This network shows the impact of papers produced by Wei Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Yang. The network helps show where Wei Yang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wei Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 3 | |
| 4 | 2023 | 3 | |
| 5 | 2022 | 110 | |
| 6 | 2022 | 41 | |
| 7 | 2022 | 8 | |
| 8 | 2022 | 5 | |
| 9 | 2021 | 78 | |
| 10 | 2021 | 2 | |
| 11 | 2021 | 15 | |
| 12 | 2020 | 58 | |
| 13 | 2018 | 2 | |
| 14 | 2018 | 23 | |
| 15 | The extract of Lycium barbarum L. improves the behavior of rats with premature ovarian by regulating related genes | 2017 | 0 |
| 16 | 2015 | 18 | |
| 17 | 2013 | 27 | |
| 18 | Clinical research of curcumin against paraquat induced lung fibrosis | 2012 | 1 |
| 19 | 2011 | 4 | |
| 20 | 2006 | 25 |
About Wei Yang
Wei Yang is a scholar working on Cancer Research, Developmental Neuroscience, Nephrology, Pharmaceutical Science and Immunology, having authored 122 papers that have together received 2.7k indexed citations. Recurring topics across this work include Hydrogen's biological and therapeutic effects (12 papers), Ferroptosis and cancer prognosis (10 papers), Inflammasome and immune disorders (9 papers), MicroRNA in disease regulation (8 papers), Cardiac Imaging and Diagnostics (7 papers), Autophagy in Disease and Therapy (7 papers), Cardiac Ischemia and Reperfusion (6 papers) and RNA modifications and cancer (5 papers). The work is most often cited by research in Pharmaceutical Science (177 citations), Cancer Research (401 citations), Developmental Neuroscience (83 citations), Pharmacology (275 citations) and Molecular Biology (1.1k citations). Wei Yang has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Robert O. Williams, Keith P. Johnston, Rongmin Yu, Liyan Song, Nathan P. Wiederhold, Chunyan Yan, Zhang Zhang, Yu Zhao, Yunan Gao and Xiuru Guan. Their work appears in journals such as Biochemical and Biophysical Research Communications, Scientific Reports, International Journal of Medical Sciences, BMC Veterinary Research and European Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.